Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,660 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06495983Recruiting
Hormone tracking and data collection in primary aldosteronism
This study tracks hormone levels and collects different health information to better understand primary aldosteronism, a condition where your adrenal glands produce too much aldosterone. It aims to improve diagnosis and care.
BergenAges 18–70 - NCT06496035Recruiting
Blood flow training for leg fracture recovery
This study tests whether a special exercise method called blood flow restriction training helps people heal faster after a broken shinbone (tibia). It might improve strength and recovery during physical therapy.
Denver, ColoradoAges 18–100 - NCT06496308RecruitingPhase 3
Adding orelabrutinib to standard therapy for mantle cell lymphoma
This trial tests adding the targeted therapy orelabrutinib (a BTK inhibitor) to standard chemotherapy (bendamustine) and immunotherapy (rituximab) for people with high-risk mantle cell lymphoma who have not had treatment before. The goal is to see if the combination works better at controlling the cancer.
ShanghaiAges 18–80 - NCT06496373RecruitingEarly Phase 1
mRNA vaccine plus immunotherapy after pancreatic cancer surgery
This trial tests a personalized mRNA vaccine combined with an immunotherapy drug (PD-1 inhibitor) to prevent pancreatic cancer from returning after surgery. It is for patients whose tumors have specific genetic features and who cannot have standard chemotherapy.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06496412Recruiting
Fecal transplant for brain health in type 1 diabetes
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
Changsha, HunanAges 18–60 - NCT06497101Recruiting
A therapy with support for adults with anorexia nervosa
This study tests a new type of therapy called Temperament Based Therapy with Support (TBT-S) for adults with anorexia nervosa. It involves bringing a support person to sessions to help with recovery.
OsloAges 18 years+ - NCT06497361RecruitingEarly Phase 1
PRG-2311 for hard-to-treat lupus nephritis and IgG4 disease
This trial tests a new treatment called PRG-2311 for people with lupus nephritis or IgG4-related disease that has not responded to standard therapies. The treatment uses a type of immune cell therapy (CAR-T) to try to control the disease.
Wuhan, HubeiAges 18 years+ - NCT06497283Recruiting
Binaural sound during anesthesia with remimazolam
This trial tests whether playing binaural sounds (special audio tones) through headphones during surgery can help people relax while under anesthesia with the drug remimazolam. It may reduce the amount of anesthesia needed and improve recovery.
SeoulAges 20 years+ - NCT06497296Recruiting
Best timing for endoscopy after lidocaine spray
This trial looks at when to start an upper endoscopy (EGD) after using a lidocaine throat spray. It aims to find the optimal waiting time to make patients more comfortable during the procedure.
Tainan, Other (Non U.s.)Ages 20–90 - NCT06497452Recruiting
Glofitamab with rescue therapy for relapsed B-cell lymphoma
This study is testing how well the drug Glofitamab works when given along with standard rescue treatments for adults with B-cell Non-Hodgkin Lymphoma that has relapsed or not responded to prior therapy. The goal is to see if this combination is effective and safe in everyday medical practice.
Suzhou, JiangsuAges 18 years+ - NCT06497387RecruitingEarly Phase 1
PRG-1801 for stubborn lupus kidney and IgG4 disease
This trial tests a new treatment called PRG-1801 for people with lupus nephritis (kidney inflammation from lupus) or IgG4-related disease that has not improved with standard treatments. The treatment uses your own immune cells to target and calm the disease.
Wuhan, HubeiAges 18 years+ - NCT06497738Recruiting
Comparing two drug combos for elderly myeloma
This trial compares two different drug combinations (DRd and VRd-lite) for older adults (65+) who are newly diagnosed with multiple myeloma. The goal is to see which combination works better and is easier to tolerate.
Changzhou, JiangsuAges 65 years+ - NCT06497712Recruiting
Hypnosis for pain during emergency room stitches
This trial tests if hypnosis can reduce pain when getting stitches in the emergency room. If you have a stitchable wound and are at least 18 years old, you may be able to join.
Clermont-FerrandAges 18 years+ - NCT06497829Recruiting
Geranylgeraniol for MVK deficiency trial
This study tests whether a natural supplement called geranylgeraniol can help people with mevalonate kinase deficiency (a rare metabolic condition). If you are 12 or older and have this diagnosis, you may be able to join.
PragueAges 12 years+ - NCT06497959RecruitingPhase 3
Ultrasound study of placenta blood flow
This trial uses a special contrast dye during ultrasound to examine blood flow in the placenta of pregnant women who have chosen to end their pregnancy for medical reasons. It may help understand the role of poor placental blood flow in severe fetal growth restriction.
NancyAges 18–64 - NCT06497868Recruiting
Self-compassion and bipolar disorder
This study looks at how self-compassion (being kind to yourself) relates to bipolar disorder. If you have bipolar disorder and have been treated outside a hospital in recent years, you may be able to help by allowing researchers to review your medical records.
Strasbourg, Les Hôpitaux Universitaires de StrasbourgAges 18 years+ - NCT06497894RecruitingPhase 4
Hormone therapy for sleep in late menopause
This trial tests whether hormone replacement therapy (HRT) can improve sleep for women in late menopause who have insomnia. If you are in late menopause and struggle with poor sleep, this study may offer a treatment option.
BernAges 45–69 - NCT06498089RecruitingPhase 4
Comparing tailored vs. standard treatment for active Takayasu's arteritis.
This trial compares a personalized treatment plan based on your specific disease markers to standard care, aiming to find which is more effective and safer for active Takayasu's arteritis. It may help researchers learn how to better control inflammation and prevent flares.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06498154RecruitingPhase 2
Skipping breast surgery for some patients after chemo
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
TianjinAges 18–70 - NCT06498297Recruiting
Reorientation Tool for Confusion in Older Hospitalized Patients
This study looks at whether a special tool that helps reorient patients in time and space can speed up recovery from confusion in older adults. It may help if you or a loved one have been in the hospital and experienced confusion.
StrasbourgAges 75 years+ - NCT06498219Recruiting
Better skin testing for iodine contrast dye allergies
This trial looks at whether doing a skin test with a full-strength (undiluted) version of contrast dye makes the test more accurate for people who have had allergic reactions to these dyes. It may help doctors figure out which contrast agent is truly causing your allergy.
StrasbourgAges 18 years+ - NCT06498310Recruiting
Fungal infections in heart transplant patients (2008–2022)
This study looks back at heart transplant patients who had a serious fungal infection from thread-like fungi (like mold) between 2008 and 2022. It aims to learn more about these infections to improve care for future patients.
StrasbourgAges 18 years+ - NCT06498362Recruiting
Levetiracetam for Seizure Emergencies in Children
This study looks back at children who had a prolonged seizure (status epilepticus) and needed a second medicine after the first one didn't work. Doctors want to see how well levetiracetam works compared to phenytoin, so they can choose better treatments for future children.
StrasbourgAges 3 months–17 years - NCT06498622RecruitingPhase 2
Liver cancer relapse prevention after surgery
This trial tests a combination of two drugs (Donafenib and Envafolimab) after surgery to lower the risk of liver cancer coming back in people who have high-risk features. It may help if you qualify based on your tumor(s) and overall health.
Fuyang, AnhuiAges 18–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,660 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.